Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

ClinVar Genomic variation as it relates to human health

Advanced search

NM_003000.2(SDHB):c.502C>T (p.Gln168Ter)

Help
Interpretation:
Pathogenic​

Review status:
criteria provided, single submitter
Submissions:
2 (Most recent: Jan 7, 2021)
Last evaluated:
Jul 3, 2017
Accession:
VCV000468234.2
Variation ID:
468234
Description:
single nucleotide variant
Help

NM_003000.2(SDHB):c.502C>T (p.Gln168Ter)

Allele ID
447473
Variant type
single nucleotide variant
Variant length
1 bp
Cytogenetic location
1p36.13
Genomic location
1: 17027787 (GRCh38) GRCh38 UCSC
1: 17354282 (GRCh37) GRCh37 UCSC
HGVS
Nucleotide Protein Molecular
consequence
NC_000001.10:g.17354282G>A
NC_000001.11:g.17027787G>A
NG_012340.1:g.31384C>T
... more HGVS
Protein change
Q168*
Other names
-
Canonical SPDI
NC_000001.11:17027786:G:A
Functional consequence
-
Global minor allele frequency (GMAF)
-

Allele frequency
-
Links
ClinGen: CA338272662
dbSNP: rs1553177677
VarSome
Help

Aggregate interpretations per condition

Interpreted condition Interpretation Number of submissions Review status Last evaluated Variation/condition record
Pathogenic 1 criteria provided, single submitter Jul 3, 2017 RCV000525973.1
Pathogenic 1 criteria provided, single submitter Jun 23, 2017 RCV001383002.1
Help
Gene OMIM ClinGen Gene Dosage Sensitivity Curation Variation viewer Related variants
HI score Help TS score Help Within gene All
SDHB Sufficient evidence for dosage pathogenicity No evidence available GRCh38
GRCh37
789 819

Submitted interpretations and evidence

Help
Interpretation
(Last evaluated)
Review status
(Assertion criteria)
Condition
(Inheritance)
Submitter Supporting information
Pathogenic
(Jul 03, 2017)
criteria provided, single submitter
Method: clinical testing
Paragangliomas 4
Allele origin: germline
Invitae
Accession: SCV000644759.1
Submitted: (Oct 05, 2017)
Evidence details
Comment:
This sequence change creates a premature translational stop signal (p.Gln168*) in the SDHB gene. It is expected to result in an absent or disrupted protein … (more)
Pathogenic
(Jun 23, 2017)
criteria provided, single submitter
Method: clinical testing
Gastrointestinal stromal tumor
Paragangliomas 4
Pheochromocytoma
Allele origin: germline
Invitae
Accession: SCV001582001.1
Submitted: (Jan 07, 2021)
Evidence details
Publications
PubMed (3)
Comment:
This sequence change creates a premature translational stop signal (p.Gln168*) in the SDHB gene. It is expected to result in an absent or disrupted protein … (more)

Functional evidence

Help
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Citations for this variant

Help
Title Author Journal Year Link
Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene. Oishi Y Endocrine journal 2010 PMID: 20505258
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Ricketts CJ Human mutation 2010 PMID: 19802898
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. Burnichon N The Journal of clinical endocrinology and metabolism 2009 PMID: 19454582

Text-mined citations for rs1553177677...

Help
These citations are identified by LitVar using the rs number, so they may include citations for more than one variant at this location. Please review the LitVar results carefully for your variant of interest.

Record last updated Oct 08, 2021